However, the nation has now been embroiled in this "war" for over 50 years, and we are nowhere closer to victory, argues ...

Here, we present you with the most up-to-date scientific facts on some frequent cancer myths and misconceptions.

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

The Phase II portion is seeking to establish safety and efficacy of the company’s HER2 breast cancer therapy in combination ...

In localized non-small cell lung cancer (NSCLC), a tumor's ability to use carbon from glucose to feed the tricarboxylic acid ...

(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Joseph Allen discussing PSA response and survival based on metastatic site in patients with ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer. The Royal ...

Aston University is collaborating in research to develop an injectable paste which could treat bone cancer.

Telix is in a strong financial position with net cash of AUD 140 million as of December 2024. We forecast free cash flow averaging 87% of net income over the next 10 years, and in the absence of major ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Annual Symposium held in San ...

Purple Biotech has entered a Phase II trial with its small molecule drug, NT219, focusing on patients with ...